ALLO vs PSX · rev $22.0K vs P/E 17, rev $143.15B
Allogene Therapeutics Inc (ALLO) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported PSX revenue for 2024-12-31 was $143.15B. Net income was $2.17B. Revenue was down 2.9% from 2023-12-31 to 2024-12-31. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
ALLO currently screens at market cap $258.1M. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the ALLO and PSX stock pages for the full models.
Not investment advice.